Investigation of Linaclotide's Effect on the Bi-directional Brain and Gut Axis in IBS-C Patients
Phase of Trial: Phase I
Latest Information Update: 10 Oct 2018
Price : $35 *
At a glance
- Drugs Linaclotide (Primary)
- Indications Irritable bowel syndrome
- Focus Pharmacodynamics
- 10 Oct 2018 Results assessing the effect of Linaclotide on cortico-anorectal (efferent) brain-gut axis, presented at the American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course 2018.
- 25 Jun 2018 Planned End Date changed from 1 Aug 2017 to 1 Jun 2018.
- 05 Jun 2018 Status changed from active, no longer recruiting to completed, according to results presented at the Digestive Disease Week 2018.